Results 261 to 270 of about 137,029 (384)

Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Existing literature largely contrasts pediatric inflammatory bowel disease (PIBD) phenotypic differences and outcomes of South Asians (SAs) with Caucasians. No published comparative data exist between SAs and non‐SAs within Asia‐Pacific.
James Guoxian Huang   +4 more
wiley   +1 more source

The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah   +4 more
wiley   +1 more source

Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis. [PDF]

open access: yesSci Rep
Tessier L   +9 more
europepmc   +1 more source

Racial Differences in Disease Characteristics of Pediatric Hidradenitis Suppurativa

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Understanding the potential racial differences in presentation, severity, and outcomes of pediatric hidradenitis suppurativa (HS) can help deliver equitable and individualized care, especially as this condition is increasingly being acknowledged in this population.
Toluwalashe Onamusi   +2 more
wiley   +1 more source

Blau Syndrome (Juvenile Systemic Granulomatosis): State‐Of‐The‐Art Review

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Blau syndrome (BlauS) is a rare pediatric autoinflammatory disorder due to NOD2 gain‐of‐function pathogenic variants characterized by a triad of granulomatous dermatitis, arthritis, and uveitis, which can progress to systemic complications if untreated.
Ou Jia (Emilie) Wang   +3 more
wiley   +1 more source

The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats. [PDF]

open access: yesBiomedicines
Menni A   +10 more
europepmc   +1 more source

Improvement of arthritis/arthralgia after treatment with infliximab (Remicade®) in a German prospective open-label multicenter trial in refractory Crohn's disease

open access: bronze, 2001
Tilo Andus   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy